← Back to Vital Edge Science
← Back to Vital Edge Science Compound Comparison Tool

How are these compounds
scientifically different?

Compare mechanisms, targets, research profiles and pharmacokinetics for up to 4 compounds side by side. This maps what is scientifically known — it does not tell you which compound to choose.

This is a scientific comparison, not a recommendation. It does not answer "which should I take?" — for potential combination-specific considerations, see the Interaction Checker; for regulatory/clinical-development history, see the Research Status Explorer.

KPV × BPC-157 × 2 of 4 selected View comparison

KPV

α-MSH-derived tripeptide

Remove
VS

BPC-157

Gastric pentadecapeptide

Remove

Target & Mechanism Comparison

Primary molecular targets for each selected compound, drawn directly from each compound's structured scientific record. Not every compound has a single conventional receptor target — where that's the case, its differentiating mechanism is noted below instead.

← Scroll to see all compounds →

Target KPVBPC-157
✓ —
— ✓

What These Compounds Share

Shared research line

All selected compounds are catalogued under Rebuild.

Key Differences

KPV IL-1-associated is a direct target of KPV that none of the other selected compounds share. A three-amino-acid α-MSH fragment researched predominantly for inflammatory rather than pigmentation biology.
BPC-157 NO-associated is a direct target of BPC-157 that none of the other selected compounds share. Large preclinical repair literature with a comparatively small human evidence base.

Compound Detail

KPV
What is it?
A tiny fragment of a natural hormone, studied for calming inflammation.
What are people researching/using it for?
Studied mainly for gut and skin inflammation.
Other uses being trialed
General inflammatory-condition research
Worth knowing
Human administration research is very limited / insufficient.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
A three-amino-acid α-MSH fragment researched predominantly for inflammatory signalling rather than pigmentation biology.
Tripeptide · 3 amino acids · Lys-Pro-Val · Derived fragment of α-MSH
Primary Targets & Biological System
Inflammatory signalling

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
The C-terminal tripeptide fragment of α-MSH, but its anti-inflammatory research findings are not simply attributed to melanocortin receptor activity the way the full α-MSH molecule's are -- some experimental work suggests KPV's effects on inflammatory signalling may occur independently of melanocortin receptors altogether. Research has implicated interference with IL-1β-associated signalling (a key inflammatory cytokine pathway) and NF-κB-related processes (a central switch for inflammatory gene expression), studied particularly in gut and skin inflammation models.
Research Areas
Inflammatory signallingIntestinal inflammatory modelsSkin inflammationImmune-cell migrationIL-1-associated biology
Research Profile
Human administration: None identified Preclinical: Available
Pharmacokinetics
Not adequately established
Research Routes
Not established in humans (descriptive only — not administration or dosing guidance)
Key Differentiator
A three-amino-acid α-MSH fragment researched predominantly for inflammatory rather than pigmentation biology.
Considerations
Research Limitations
Human administration research is very limited / insufficient.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

Psoriasis / eczema
Preclinical skin-inflammation research has investigated topical KPV for inflammatory skin conditions, extending from its gut-inflammation research base. No established human dermatology evidence.
Availability & Sources
Current Vital Edge Testing
Batch 2 · tested Oct 2026 · 99.036% purity, 11.08mg content Purity/ID report
Available As (Vital Edge Science)
KPV · A$49.95 A$64.95
Browse products →
View Research Sources (1) →
Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides
Preclinical (animal) · PMID 12750433

Supports treating KPV's anti-inflammatory effects as potentially receptor-independent rather than a conventional melanocortin agonist action.

Supports: mechanism_summary, key_differentiator

BPC-157
What is it?
A peptide derived from a protective stomach protein.
What are people researching/using it for?
Studied mainly in animal models for gut healing and tissue repair.
Other uses being trialed
Tendon and ligament recovery researchGeneral injury-repair research
Worth knowing
A large preclinical repair literature exists alongside a very small human evidence base -- the human pilot data available come from uncontrolled studies with very small samples (one IV safety pilot enrolled only two participants); this is not robust clinical evidence and should not be presented as established human effects.

Simplified for general understanding. Switch to "Full science" above for the complete research-level detail, targets, pharmacokinetics and sources.

Identity
What is it?
A pentadecapeptide researched across GI, tendon/ligament and wound-repair models, with no single clinically established mechanism.
15-amino-acid peptide · 15 amino acids · Synthetic, derived from a gastric protective peptide
Primary Targets & Biological System
Gastrointestinal / tissue repair

Tap a target above for a plain-language explanation.

Mechanism & Research Profile
How does it work?
No single receptor or clinically established mechanism has been identified for BPC-157 to date. Preclinical research has implicated several overlapping pathways: effects on nitric-oxide signalling (involved in blood-vessel dilation and tissue protection), promotion of angiogenesis, general cytoprotective effects on gut and tissue linings, and interactions with growth-factor pathways involved in tissue repair. Because these findings come from a large body of animal and in-vitro work without a confirmed unifying receptor, mechanism-level claims about BPC-157 should be read as multiple proposed, overlapping hypotheses rather than one settled pathway.
Research Areas
GI tissue modelsTendon/ligament modelsWound repairAngiogenesisNitric-oxide-associated signallingTissue injuryInflammatory models
Research Profile
Human administration: Limited Preclinical: Extensive
Pharmacokinetics
No adequately powered human PK study identified; available human pilot data are from very small, uncontrolled samples.
Research Routes
Subcutaneous (research contexts) (descriptive only — not administration or dosing guidance)
Key Differentiator
Large preclinical repair literature with a comparatively small human evidence base.
Considerations
Research Limitations
A large preclinical repair literature exists alongside a very small human evidence base -- the human pilot data available come from uncontrolled studies with very small samples (one IV safety pilot enrolled only two participants); this is not robust clinical evidence and should not be presented as established human effects.
Experimental / Off-Label Research

Not an approved or established use. These are active or emerging research directions found in the literature, shown for informational context only — not a claim that this compound is approved, effective, or safe for these purposes.

Neuroprotection / brain injury
Mouse traumatic-brain-injury studies have reported reduced brain lesions and improved early outcomes with BPC-157. This research is exclusively in animal models -- a 2024 narrative review identified only three small human pilot studies of BPC-157 overall, none specifically designed to test neuroprotective effects.
Availability & Sources
Current Vital Edge Testing
Batch 3 · tested Nov 2026 · 99.751% purity, 13.67mg content Purity/ID report
Available As (Vital Edge Science)
BPC-157 · A$64.95 A$74.95
Browse products →
View Research Sources (2) →
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Human Human · Two participants · Intravenous · PMID 40131143

Only 2 participants -- not treated as robust clinical evidence on this record.

Supports: research_limitations, human_administration_status

Additional human pilot study
Human Human · PMID 39325560

Small, uncontrolled human evidence.

Supports: research_limitations

Common Research Comparisons

Frequently studied groupings — not recommendations.

Browse more compounds

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Choose a compound

Metabolic

5-Amino-1MQ

NNMT inhibitor

NNMTNicotinamideNAD MetabolismSmall Molecule
Rebuild

BPC-157

Gastric pentadecapeptide

GI ResearchTissue RepairAngiogenesisNO-associated
Metabolic

Cagrilintide

Long-acting amylin analogue

AmylinSatietyAppetiteMetabolic
Peak

CJC-1295

Modified GHRH analogue

GHRHRModified GRFGHIGF-1
Neuro

DSIP

Neuropeptide

Sleep ResearchNeuropeptideNeuroendocrineCNS
Rebuild

Epithalon

Synthetic tetrapeptide

Telomere ResearchTelomeraseCellular AgeingTetrapeptide
Rebuild

GHK-Cu

Copper-binding tripeptide

Copper PeptideECMFibroblastCollagen
Peak

GHRP-2

GH-releasing peptide / GH secretagogue

GHSR1aGhrelinGH SecretagogueAppetite
Rebuild

Glutathione

Endogenous antioxidant tripeptide

GSHRedoxAntioxidantOxidative Stress
Metabolic

HCG

Glycoprotein hormone

LHCGRReproductive AxisGonadalEndocrine
Reference

IGF-1 LR3

IGF-1 receptor agonist (engineered analogue)

IGF1RGrowth FactorPI3K/AKTRAS/MAPK
Peak

Ipamorelin

GH secretagogue

GHSR1aGH SecretagogueGhrelin PathwayGH
Enhance

Kisspeptin-10

Kisspeptin fragment

KISS1RGnRHLHFSH
Rebuild

KPV

α-MSH-derived tripeptide

KPVα-MSH FragmentInflammationIL-1-associated
Enhance

Melanotan I

α-MSH analogue

MC1RMelanocortinPigmentationα-MSH Analogue
Enhance

Melanotan II

Cyclic melanocortin agonist

MelanocortinMC ReceptorsPigmentationCyclic Peptide
Metabolic

MOTS-c

Mitochondrial-derived peptide

MitochondrialAMPK-associatedMetabolicExercise Biology
Metabolic

NAD+

Cellular redox cofactor

NAD+RedoxCellular EnergySirtuins
Enhance

PT-141

Cyclic melanocortin receptor agonist

MelanocortinMC4R-associatedCNSSexual Response
Metabolic

Retatrutide

Triple receptor agonist

GLP-1RGIPRGCGRIncretin
Reference

rHGH (Somatropin)

Growth hormone receptor agonist

GHRIGF-1Growth HormonePituitary-independent
Neuro

Selank

Synthetic tuftsin analogue

Tuftsin AnalogueCNSStress ResearchNeurotransmitter Research
Metabolic

Semaglutide

GLP-1 receptor agonist

GLP-1RIncretinMetabolicGlucose
Neuro

Semax

Synthetic ACTH-fragment analogue

ACTH FragmentNeurotrophinBDNF-associatedCNS
Peak

Sermorelin

GHRH fragment analogue

GHRHRGHRH(1-29)PituitaryGH
Rebuild

SS-31

Mitochondria-targeting tetrapeptide

MitochondriaCardiolipinInner Mitochondrial MembraneBioenergetics
Peak

Tesamorelin

Stabilised GHRH analogue

GHRHRGHIGF-1Pituitary
Rebuild

Thymosin Alpha-1

Thymic peptide

ImmuneT CellsTLR-associatedInnate Immunity
Rebuild

Thymosin Beta-4 (TB-4)

Thymosin Beta-4

Thymosin Beta-4Actin BiologyCell MigrationRepair Research
Metabolic

Tirzepatide

Dual incretin receptor agonist

GIPRGLP-1RDual AgonistIncretin

Simplified for general understanding — see this compound's "How does it work?" section for the full research-level description.